Tag: hospital acquired infections testing kits market drivers

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Hospital Acquired Infections Testing Kits Market Poised To Hit $7.2 Billion By 2030 With A 8.5% CAGR

The market size for hospital acquired infections testing kits has shown strong expansion in recent years. It is projected to increase from $4.79 billion in 2025 to $5.19 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.5%. The expansion witnessed in the past can be credited to factors like the rise in hospital infection surveillance, the growing occurrence of antibiotic-resistant pathogens, the expansion of clinical microbiology laboratories, the execution of infection control protocols, and the accessibility of molecular diagnostic tools.

The market for hospital acquired infections testing kits is expected to demonstrate significant expansion in the coming years. This sector is projected to reach $7.2 billion in 2030, achieving a compound annual growth rate (CAGR) of 8.5%. The projected growth during this period can be attributed to a heightened focus on early infection detection, increased investments in hospital safety infrastructure, the expanding adoption of rapid testing, a growing demand for automated diagnostic workflows, and advancements in molecular diagnostics technology. Prominent trends expected in the forecast period include the increasing uptake of rapid diagnostic test kits, a rise in the use of molecular testing for HAIs, the growing integration of automated diagnostic instruments, the expansion of point-of-care infection testing, and an enhanced emphasis on multi-pathogen detection.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=30376512&type=smp&name=Hospital%20Acquired%20Infections%20Testing%20Kits%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Hospital Acquired Infections Testing Kits Market Growth Catalysts And Demand Drivers

The expansion in healthcare settings is projected to boost the hospital-acquired infections testing kits market going forward. Within these settings, a broad spectrum of facilities exists, such as acute care hospitals, urgent care centers, rehabilitation centers, nursing homes, and long-term care facilities, providing diverse healthcare services. Crucially, hospital-acquired infections testing kits serve as essential instruments for identifying and averting nosocomial infections, thereby improving patient safety within medical establishments. As an illustration, data from the American Hospital Association, a US-based healthcare industry trade group, indicated a substantial rise in the total number of hospitals across the U.S. region from 6,093 in 2022 to 60,129 in 2023, as of May 2023. Furthermore, community hospital admissions grew from 31,393,318 in 2022 to 31,967,073 in 2023. Consequently, the increasing prevalence of healthcare settings fuels the hospital-acquired infections testing kits market.

Hospital Acquired Infections Testing Kits Market Segments: Where Is Growth Concentrated?

The hospital acquired infections testing kits market covered in this report is segmented –

1) By Product: Consumables And Reagents, Instruments

2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others

3) By Pathogen Type: Viral, Bacterial, Fungal

4) By Application: Drug Resistance Testing, Disease Testing

Subsegments:

1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)

2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)

Hospital Acquired Infections Testing Kits Market Trends Shaping Long-Term Demand

Leading companies active in the hospital-acquired infections (HAI) testing kits market are prioritizing the development of advanced point-of-care antimicrobial susceptibility testing (AST) solutions. This focus aims to enable rapid diagnosis, guide specific therapies, and combat antimicrobial resistance (AMR). Point-of-care AST employs proprietary microfluidic technology to swiftly identify bacterial presence and evaluate antibiotic effectiveness directly from patient urine samples, thereby reducing diagnostic delays and improving treatment decisions. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, introduced the world’s first point-of-care testing system in Europe designed to perform antimicrobial susceptibility testing in just 30 minutes. By utilizing a microfluidic-based AST approach for patients with suspected urinary tract infections, the system significantly cuts down turnaround time and supports antimicrobial stewardship in primary care settings through enabling timely and informed antibiotic use, consequently contributing to global efforts to curb AMR.

Hospital Acquired Infections Testing Kits Market Leading Companies And Competitive Benchmarking

Major companies operating in the hospital acquired infections testing kits market are Becton Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, GE Healthcare, Seegene, SD Biosensor, Fujirebio, Sysmex Corporation, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, ImmunoScience, Vivacheck Lab

View The Full Hospital Acquired Infections Testing Kits Market Report:

https://thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Hospital Acquired Infections Testing Kits Market Top Region By Revenue And Market Share

North America was the largest region in the hospital-acquired infections testing kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The hospital-acquired infections testing kits market has witnessed substantial growth in recent years and shows promising prospects for the future. With rising concerns about infections contracted within healthcare environments, this market is becoming increasingly vital for improving patient safety and optimizing infection control measures. Let’s explore the current market size, driving factors, key players, emerging trends, and regional insights shaping this important sector.

Hospital Acquired Infections Testing Kits Market Size and Expected Growth

The hospital-acquired infections testing kits market has grown significantly and is projected to expand further, increasing from $4.79 billion in 2025 to $5.19 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. This historical growth has been driven by enhanced infection surveillance in hospitals, a rise in antibiotic-resistant pathogens, the expansion of clinical microbiology laboratories, better infection control protocols, and the availability of advanced molecular diagnostic tools. Looking ahead, the market is forecast to reach $7.2 billion by 2030, maintaining the same CAGR of 8.5%. Factors such as heightened focus on early infection detection, increased investment in hospital safety infrastructure, broader adoption of rapid testing methods, growing demand for automated diagnostic workflows, and technological advances in molecular diagnostics will continue to underpin this growth. Key trends expected to influence the market include increased use of rapid diagnostic test kits, expanded molecular testing for hospital-acquired infections, integration of automated diagnostic instruments, growth in point-of-care infection testing, and a stronger emphasis on detecting multiple pathogens simultaneously.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp

Expanding Healthcare Settings as a Major Growth Driver in the Hospital Acquired Infections Testing Kits Market

The growing number of healthcare facilities worldwide is playing a crucial role in driving demand for hospital-acquired infections testing kits. Healthcare settings encompass a variety of institutions such as acute care hospitals, urgent care centers, rehabilitation facilities, nursing homes, and long-term care facilities, all of which require robust infection detection and prevention tools to ensure patient safety. For example, in May 2023, the American Hospital Association reported a significant increase in the total number of hospitals in the U.S., rising from 6,093 in 2022 to 60,129 in 2023. Alongside this, admissions in community hospitals also grew from over 31.3 million in 2022 to nearly 32 million in 2023. This expansion of healthcare infrastructure directly feeds into the rising need for infection testing kits.

Impact of Growing Surgical Procedures on the Hospital Acquired Infections Testing Kits Market

Another important factor boosting the hospital-acquired infections testing kits market is the rise in surgical procedures. Surgical operations, which involve incisions and require anesthesia or sedation, create potential entry points for infections, thus increasing the necessity for effective infection detection methods. The aging global population is a significant contributor to this trend, as older adults typically require more medical interventions related to chronic and age-related health issues. Evidence of this growth is seen in Australia, where hospitalizations involving surgery rose from 3.0 million cases in 2022-23 to 3.1 million cases in 2023-24, an increase of 100,000. Such increases in surgical volume naturally fuel demand for diagnostic kits that help monitor and manage postoperative infections.

Access The Complete Hospital Acquired Infections Testing Kits Market Report:

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Product and Test Type Segments Defining the Hospital Acquired Infections Testing Kits Market

The hospital-acquired infections testing kits market is divided into several key segments that highlight its diverse product offerings and applications. By product, the market is split into consumables and reagents as well as instruments. Consumables and reagents include culture media used for pathogen isolation and identification, molecular testing reagents such as PCR kits, rapid test kits for various infections, and other related supplies like swabs and preservation solutions. Instrument categories cover automated analyzers for blood culture and pathogen identification, molecular diagnostic devices for PCR and other methods, microscopes, and incubators used for culturing samples. Test types focus on infections such as pneumonia, urinary tract infections, bloodstream infections, surgical site infections, MRSA infections, and others. Additionally, pathogen types are classified into viral, bacterial, and fungal, while application areas revolve around drug resistance testing and disease diagnostics.

Emerging Trends Shaping the Future of the Hospital Acquired Infections Testing Kits Market

Recent innovations in the hospital-acquired infections testing kits market emphasize the development of rapid point-of-care antimicrobial susceptibility testing (AST) solutions. These technologies enable faster diagnosis, guide more effective targeted therapies, and help combat the global challenge of antimicrobial resistance (AMR). Point-of-care AST systems use advanced microfluidic technology to quickly identify bacterial infections and assess antibiotic efficacy from patient samples, reducing diagnostic delays and improving treatment decisions. For example, in June 2023, Japan-based Sysmex Corporation launched the first point-of-care AST system in Europe capable of delivering results in just 30 minutes for urinary tract infections. This breakthrough technology supports antimicrobial stewardship by enabling timely and accurate antibiotic administration in primary care settings, contributing to global AMR mitigation efforts.

Key Players Leading the Hospital Acquired Infections Testing Kits Market

The hospital-acquired infections testing kits market features several prominent companies driving innovation and competition. Some of the major players include Becton Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, GE Healthcare, Seegene, SD Biosensor, Fujirebio, Sysmex Corporation, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, ImmunoScience, and Vivacheck Lab. These organizations are actively involved in advancing diagnostic technologies and expanding product portfolios to meet growing market demands.

Regional Market Leadership and Growth Outlook in Hospital Acquired Infections Testing Kits

In 2025, North America held the largest share of the hospital-acquired infections testing kits market, reflecting its well-established healthcare infrastructure and high adoption of advanced diagnostic tools. Meanwhile, the Asia-Pacific region is expected to experience the fastest growth during the forecast period, driven by increasing healthcare investments, expanding hospital networks, and rising awareness of infection control. The market analysis encompasses key regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

By 2030, How Much Growth In Market Size Is Expected For The Hospital Acquired Infections Testing Kits Market?

Significant expansion has been observed in the hospital acquired infections testing kits market size during recent years. This market is projected to grow from $4.79 billion in 2025 to $5.19 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.5%. The historical rise in this market can be attributed to elements such as increasing hospital infection surveillance, the escalating prevalence of antibiotic-resistant pathogens, the enlargement of clinical microbiology laboratories, the implementation of infection control protocols, and the widespread availability of molecular diagnostic tools.

The hospital acquired infections testing kits market is projected to experience substantial expansion in the coming years. This market is set to reach a valuation of $7.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. Factors driving this growth during the projected period include a heightened emphasis on prompt infection identification, increased capital allocation for hospital safety infrastructure, the wider embrace of rapid testing methods, an escalating need for automated diagnostic processes, and innovations in molecular diagnostics technology. Key trends anticipated over the forecast period encompass the surging acceptance of rapid diagnostic test kits, a greater reliance on molecular testing for HAIs, the increasing incorporation of automated diagnostic equipment, the broadening scope of point-of-care infection testing, and a sharpened focus on detecting multiple pathogens.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp

Which Drivers Are Advancing The Hospital Acquired Infections Testing Kits Market Growth?

The expansion in the number of healthcare settings is anticipated to fuel the growth of the hospital-acquired infections testing kits market in the future. Within these settings, a broad spectrum of healthcare facilities and services, such as acute care hospitals, urgent care centers, rehabilitation facilities, nursing homes, and long-term care facilities, are available, providing extensive healthcare options. Hospital-acquired infections testing kits serve as essential instruments for identifying and preventing healthcare-associated infections, thereby improving patient safety within these healthcare environments. For example, data from May 2023, cited by the American Hospital Association, a US-based healthcare industry trade group, indicates a notable increase in the total number of hospitals across the U.S. region, climbing from 6,093 in 2022 to 60,129 in 2023. Concurrently, admissions in community hospitals also expanded, rising from 31,393,318 in 2022 to 31,967,073 in 2023. Consequently, the growing prevalence of healthcare settings is a key driver for the hospital-acquired infections testing kits market.

What Key Segment Areas Are Included In The Hospital Acquired Infections Testing Kits Market Assessment?

The hospital acquired infections testing kits market covered in this report is segmented –

1) By Product: Consumables And Reagents, Instruments

2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others

3) By Pathogen Type: Viral, Bacterial, Fungal

4) By Application: Drug Resistance Testing, Disease Testing

Subsegments:

1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)

2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)

Which Trends Are Guiding The Development Of The Hospital Acquired Infections Testing Kits Market?

Leading companies in the hospital-acquired infections (HAI) testing kits market are concentrating on developing advanced point-of-care antimicrobial susceptibility testing (AST) solutions to enable rapid diagnosis, guide targeted therapy, and combat antimicrobial resistance (AMR). Point-of-care AST employs proprietary microfluidic technology to quickly identify bacterial presence and evaluate antibiotic effectiveness directly from patient urine samples, thereby reducing diagnostic delays and improving treatment decisions. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, unveiled the world’s first point-of-care testing system in Europe capable of executing antimicrobial susceptibility testing in just 30 minutes. Utilizing a microfluidic-based AST approach for patients with suspected urinary tract infections, the system significantly decreases turnaround time and supports antimicrobial stewardship in primary care settings by allowing for timely and informed antibiotic use, thus contributing to global efforts to curb AMR.

Which Key Players Are Active In The Hospital Acquired Infections Testing Kits Market?

Major companies operating in the hospital acquired infections testing kits market are Becton Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, GE Healthcare, Seegene, SD Biosensor, Fujirebio, Sysmex Corporation, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, ImmunoScience, Vivacheck Lab

Access The Complete Hospital Acquired Infections Testing Kits Market Report:

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Which Regional Market Leads The Hospital Acquired Infections Testing Kits Market?

North America was the largest region in the hospital-acquired infections testing kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Hospital Acquired Infections Testing Kits Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Browse Through More Reports Similar to the Global Hospital Acquired Infections Testing Kits Market 2026, By The Business Research Company

Viral Diagnostic Test Kits Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

Infection Control Supplies Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report

Hospital Acquired Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Hospital Acquired Infections Testing Kits Market Between 2026 And 2030?

The market size for hospital acquired infections testing kits has seen substantial growth recently. This market is projected to expand from $4.79 billion in 2025 to $5.19 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.5%. The expansion observed in the historic period is due to increasing hospital infection surveillance, the rising prevalence of antibiotic-resistant pathogens, the expansion of clinical microbiology labs, the implementation of infection control protocols, and the availability of molecular diagnostic tools.

The hospital acquired infections testing kits market size is projected to experience robust expansion in the coming years. This market is anticipated to reach $7.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. Factors driving this growth during the forecast period include a heightened emphasis on prompt infection identification, increased capital allocation for hospital safety infrastructure, wider adoption of rapid testing methods, an escalating need for automated diagnostic processes, and progress in molecular diagnostics technology. Key trends observed within the forecast timeframe involve the growing uptake of rapid diagnostic test kits, increased application of molecular testing for HAIs, expanding incorporation of automated diagnostic instruments, the broadening scope of point-of-care infection testing, and a stronger focus on detecting multiple pathogens.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp

What Significant Factors Are Influencing The Hospital Acquired Infections Testing Kits Market Expansion?

The increasing number of healthcare settings is anticipated to drive the expansion of the hospital-acquired infections testing kits market in the future. Within a healthcare setting, a wide array of facilities and services are available, including acute care hospitals, urgent care centers, rehabilitation facilities, nursing homes, and long-term care facilities, which together provide comprehensive healthcare solutions. Hospital-acquired infections testing kits are essential tools for detecting and preventing nosocomial infections, thereby improving patient safety in healthcare facilities. For instance, in May 2023, the American Hospital Association, a US-based healthcare industry trade group, reported a significant increase in the total number of hospitals in the U.S. region, rising from 6,093 in 2022 to 60,129 in 2023. Additionally, community hospital admissions also grew, going from 31,393,318 in 2022 to 31,967,073 in 2023. Hence, the rising prevalence of healthcare settings is a key factor propelling the hospital-acquired infections testing kits market.

Which Segment Types Are Examined In The Hospital Acquired Infections Testing Kits Market Segment Study?

The hospital acquired infections testing kits market covered in this report is segmented –

1) By Product: Consumables And Reagents, Instruments

2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others

3) By Pathogen Type: Viral, Bacterial, Fungal

4) By Application: Drug Resistance Testing, Disease Testing

Subsegments:

1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)

2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)

What Trends Are Affecting The Direction Of The Hospital Acquired Infections Testing Kits Market?

Major companies in the hospital-acquired infections (HAI) testing kits market are focusing on developing advanced point-of-care antimicrobial susceptibility testing (AST) solutions to enable rapid diagnosis, guide targeted therapy, and combat antimicrobial resistance (AMR). Point-of-care AST leverages proprietary microfluidic technology to quickly detect bacterial presence and assess antibiotic effectiveness directly from patient urine samples, reducing diagnostic delays and improving treatment decisions. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, introduced the world’s first point-of-care testing system in Europe capable of performing antimicrobial susceptibility testing in just 30 minutes. Using a microfluidic-based AST approach for patients suspected of urinary tract infections, the system significantly reduces turnaround time and supports antimicrobial stewardship in primary care settings by enabling timely and informed antibiotic use, thereby contributing to global efforts to curb AMR.

Which Players Are Part Of The Competitive Landscape Of The Hospital Acquired Infections Testing Kits Market?

Major companies operating in the hospital acquired infections testing kits market are Becton Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, GE Healthcare, Seegene, SD Biosensor, Fujirebio, Sysmex Corporation, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, ImmunoScience, Vivacheck Lab

Get The Full Hospital Acquired Infections Testing Kits Market Report:

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Which Region Holds The Highest Market Share In The Hospital Acquired Infections Testing Kits Market?

North America was the largest region in the hospital-acquired infections testing kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Hospital Acquired Infections Testing Kits Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=2469&type=smp

Browse Through More Reports Similar to the Global Hospital Acquired Infections Testing Kits Market 2026, By The Business Research Company

Viral Diagnostic Test Kits Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

Infection Control Supplies Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report

Hospital Acquired Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Hospital Acquired Infections Testing Kits Market Evolve From 2026 To 2030?

The hospital acquired infections testing kits market size has demonstrated significant growth in recent years. It is anticipated to expand from $4.79 billion in 2025 to $5.19 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.5%. Historically, this expansion can be ascribed to several factors, including heightened hospital infection surveillance, the escalating prevalence of antibiotic-resistant pathogens, the broadening of clinical microbiology laboratories, the application of infection control protocols, and the accessibility of molecular diagnostic tools.

The market size for hospital acquired infections testing kits is anticipated to demonstrate significant expansion over the next few years, projected to reach $7.2 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. This forecasted growth is driven by a heightened focus on early infection detection, increased investments in hospital safety infrastructure, the broader adoption of rapid testing methods, a rising demand for automated diagnostic workflows, and advances in molecular diagnostics technology. Prominent trends within this period include the increased uptake of rapid diagnostic test kits, the growing utilization of molecular testing for HAIs, enhanced integration of automated diagnostic instruments, the expansion of point-of-care infection testing, and a stronger emphasis on multi-pathogen detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp

What Key Drivers Are Influencing The Growth Of The Hospital Acquired Infections Testing Kits Market?

The increasing number of healthcare facilities is projected to drive the expansion of the hospital-acquired infections testing kits market moving forward. Within a healthcare setting, a wide array of facilities and services are available, including acute care hospitals, urgent care centers, rehabilitation centers, nursing homes, and long-term care facilities, all working together to provide comprehensive healthcare solutions. Hospital-acquired infections testing kits are crucial tools for detecting and preventing infections acquired in healthcare environments, thereby enhancing patient safety. For instance, in May 2023, the American Hospital Association, a US-based healthcare industry trade group, reported a significant increase in the total number of hospitals across the U.S. region, rising from 6,093 in 2022 to 60,129 in 2023. Additionally, admissions in community hospitals also grew, climbing from 31,393,318 in 2022 to 31,967,073 in 2023. Thus, the growing presence of healthcare settings is propelling the hospital-acquired infections testing kits market.

Which Segment Areas Are Covered In The Hospital Acquired Infections Testing Kits Market Analysis?

The hospital acquired infections testing kits market covered in this report is segmented –

1) By Product: Consumables And Reagents, Instruments

2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others

3) By Pathogen Type: Viral, Bacterial, Fungal

4) By Application: Drug Resistance Testing, Disease Testing

Subsegments:

1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)

2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)

What Key Developments And Trends Are Impacting The Hospital Acquired Infections Testing Kits Market?

Leading companies operating within the hospital-acquired infections (HAI) testing kits market are increasingly concentrating on developing advanced point-of-care antimicrobial susceptibility testing (AST) solutions. These solutions aim to facilitate rapid diagnosis, guide targeted therapy, and effectively combat antimicrobial resistance (AMR). Point-of-care AST technology harnesses proprietary microfluidics to swiftly detect bacterial presence and assess antibiotic effectiveness directly from patient urine samples, thereby minimizing diagnostic delays and enhancing treatment decisions. As an illustration, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, unveiled the world’s first point-of-care testing system in Europe capable of performing antimicrobial susceptibility testing in just 30 minutes. This system, which employs a microfluidic-based AST approach for patients with suspected urinary tract infections, significantly reduces turnaround time and bolsters antimicrobial stewardship in primary care settings by enabling the timely and informed use of antibiotics, consequently supporting global endeavors to curb AMR.

Which Global Companies Are Actively Competing In The Hospital Acquired Infections Testing Kits Market?

Major companies operating in the hospital acquired infections testing kits market are Becton Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, GE Healthcare, Seegene, SD Biosensor, Fujirebio, Sysmex Corporation, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, ImmunoScience, Vivacheck Lab

Read the full hospital acquired infections testing kits market report here:

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Hospital Acquired Infections Testing Kits Market?

North America was the largest region in the hospital-acquired infections testing kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hospital Acquired Infections Testing Kits Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2469&type=smp

Browse Through More Reports Similar to the Global Hospital Acquired Infections Testing Kits Market 2026, By The Business Research Company

Viral Diagnostic Test Kits Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

Infection Control Supplies Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report

Hospital Acquired Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Hospital Acquired Infections Testing Kits Market expected to reach by 2030?

The hospital acquired infections testing kits market size has demonstrated significant expansion in recent years. It is anticipated to increase from $4.79 billion in 2025 to $5.19 billion in 2026, with a compound annual growth rate (CAGR) of 8.5%. This historical growth can be attributed to several factors including increased hospital infection surveillance, the rising prevalence of antibiotic-resistant pathogens, the expansion of clinical microbiology laboratories, the implementation of stringent infection control protocols, and the greater availability of molecular diagnostic tools.

The hospital acquired infections testing kits market size is projected to experience robust expansion over the coming years. This market is anticipated to reach $7.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. Factors contributing to this growth during the forecast period include a heightened emphasis on early detection of infections, increased investments in hospital safety infrastructure, wider adoption of rapid testing, a growing need for automated diagnostic processes, and innovations in molecular diagnostics technology. Key trends defining the forecast period involve the rising uptake of rapid diagnostic test kits, increased application of molecular testing for HAIs, greater integration of automated diagnostic tools, the broadening scope of point-of-care infection testing, and a stronger focus on identifying multiple pathogens.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp

What Drivers Are Driving Adoption Within The Hospital Acquired Infections Testing Kits Market?

The expanding presence of healthcare settings is projected to fuel the advancement of the hospital-acquired infections testing kits market in the future. Healthcare settings encompass a range of facilities and services, such as acute care hospitals, urgent care centers, rehabilitation facilities, nursing homes, and long-term care facilities, which together provide extensive healthcare options. These hospital-acquired infections testing kits are crucial instruments for identifying and averting nosocomial infections, thereby improving patient safety within healthcare facilities. An example of this trend is observed in May 2023, when the American Hospital Association, a US-based healthcare industry trade group, reported a substantial rise in the total number of hospitals in the U.S. region, increasing from 6,093 in 2022 to 60,129 in 2023. Moreover, community hospital admissions also climbed from 31,393,318 in 2022 to 31,967,073 in 2023. Consequently, the increasing volume of healthcare settings propels the hospital-acquired infections testing kits market.

What Segments Are Included Within The Hospital Acquired Infections Testing Kits Market?

The hospital acquired infections testing kits market covered in this report is segmented –

1) By Product: Consumables And Reagents, Instruments

2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others

3) By Pathogen Type: Viral, Bacterial, Fungal

4) By Application: Drug Resistance Testing, Disease Testing

Subsegments:

1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)

2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)

Which Trends Are Influencing The Development Of The Hospital Acquired Infections Testing Kits Market?

Leading companies operating in the hospital-acquired infections (HAI) testing kits market are focusing on developing advanced point-of-care antimicrobial susceptibility testing (AST) solutions to enable rapid diagnosis, guide targeted therapy, and combat antimicrobial resistance (AMR). This point-of-care AST leverages proprietary microfluidic technology to quickly detect bacterial presence and assess antibiotic effectiveness directly from patient urine samples, thereby reducing diagnostic delays and improving treatment decisions. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, introduced the world’s first point-of-care testing system in Europe capable of performing antimicrobial susceptibility testing in just 30 minutes. Utilizing a microfluidic-based AST approach for patients suspected of urinary tract infections, the system significantly reduces turnaround time and supports antimicrobial stewardship in primary care settings by enabling timely and informed antibiotic use, consequently contributing to global efforts to curb AMR.

Who Are The Top-Performing Companies In The Hospital Acquired Infections Testing Kits Market In Recent Years?

Major companies operating in the hospital acquired infections testing kits market are Becton Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, GE Healthcare, Seegene, SD Biosensor, Fujirebio, Sysmex Corporation, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, ImmunoScience, Vivacheck Lab

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Which Region Currently Holds The Largest Share Of The Hospital Acquired Infections Testing Kits Market?

North America was the largest region in the hospital-acquired infections testing kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hospital Acquired Infections Testing Kits Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2469&type=smp

Browse Through More Reports Similar to the Global Hospital Acquired Infections Testing Kits Market 2026, By The Business Research Company

Viral Diagnostic Test Kits Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report

Infection Control Supplies Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report

Hospital Acquired Infection Control Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the hospital acquired infections testing kits market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Hospital Acquired Infections Testing Kits Market Now And By 2029?

The hospital acquired infections testing kits market size has shown strong growth in recent years. It is anticipated to increase from $4.54 billion in 2024 to $4.79 billion in 2025, at a compound annual growth rate (CAGR) of 5.4%. This historical growth can be attributed to a surge in hospital-acquired infections (HAIs), an expanding aging population, and a higher volume of surgical procedures.

The market for hospital acquired infections testing kits is projected to experience substantial expansion in the coming years. This market is anticipated to reach $6.64 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.5%. This expansion during the projection period stems from factors such as a rise in chronic diseases, increased healthcare spending, and augmented government backing. Key developments anticipated in the forecast timeframe involve collaborations with artificial intelligence firms, utilizing government assistance, integrating big data into market assessments, and forging partnerships with other industry participants.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp

Which Long-Term Drivers Are Expected To Sustain The Hospital Acquired Infections Testing Kits Market?

Hospital-acquired infections (HAIs) are experiencing a rise, impacting both individuals admitted to hospitals and those visiting for outpatient care. These infections, also termed nosocomial infections, are illnesses contracted within hospital environments and medical clinics. For example, according to data from the Center for Disease Control and Prevention, about **1.7 million** people in the **USA** contract hospital-acquired infections while being hospitalized for other health concerns, and more than **98,000** (approximately **5%**) patients die as a result of these infections. The escalating occurrence of hospital-acquired infections subsequently boosts the demand for the **hospital-acquired infections testing kits market**.

How Is The Hospital Acquired Infections Testing Kits Market Classified By Different Segments?

The hospital acquired infections testing kitsmarket covered in this report is segmented –

1) By Product: Consumables And Reagents, Instruments

2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others

3) By Pathogen Type: Viral, Bacterial, Fungal

4) By Application: Drug Resistance Testing, Disease Testing

Subsegments:

1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)

2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)

What Current And Upcoming Trends Are Shaping The Hospital Acquired Infections Testing Kits Market?

Technologies utilized in diagnosing healthcare-associated infections (HAIs), encompassing flow cytometry, mass spectrometry, near-infrared spectroscopy, and nucleic acid-based methods, are experiencing technological advancements, leading to the provision of more precise data. A notable progression has occurred in mass spectrometers, which are now able to quantify identified materials and pinpoint unknown compounds within a sample. For instance, SCIEX’s X500 QTOF addresses contamination challenges and serves as a compact device that maintains high resolution and accuracy. It expedites result generation, empowering operators to make data-driven decisions more swiftly.

Who Are The Primary Market Leaders In The Hospital Acquired Infections Testing Kits Market?

Major companies operating in the hospital acquired infections testing kits market include Becton, Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, Hologic, Inc, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, Metall Zug (Belimed Group), Innovaccer, JD Health, CISCO Systems Inc, GE Healthcare, Honeywell Lifesciences, Zydus Cadila, ImmunoScience, CPC Diagnostics, Seegene, SD Biosensor, Vivacheck Lab, Fujirebio, Sysmex Corporation, Philip Healthcare, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, Bayer AG, Cantel Medical Corporation, Siemens Healthineers

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Hospital Acquired Infections Testing Kits Market?

North America was the largest region in the hospital-acquired infections testing kits market in 2024. Western Europe was the second largest region in the global hospital-acquired infections testing kits market share. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2469&type=smp

Browse Through More Reports Similar to the Global Hospital Acquired Infections Testing Kits Market 2025, By The Business Research Company

Hospital Acquired Infection Control Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Healthcare Personal Protective Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-personal-protective-equipment-global-market-report

Hospital Supplies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-supplies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Hospital Acquired Infections Testing Kits Market Between 2025 And 2029?

The overall valuation of the market for testing kits aimed at hospital-acquired infections has experienced robust expansion recently, projecting an increase from $4.54 billion in 2024 to $4.79 billion in 2025, reflecting a compound annual growth rate (CAGR) calculation of 5.4%; this momentum in the past period was fueled by a rise in HAI occurrences, a growing elderly demographic, and a higher volume of surgical procedures being performed.

Projections indicate robust expansion for the market centered on hospital-acquired infection testing kits, anticipating it to reach a valuation of $6.64 billion by 2029, fueled by an 8.5% compound annual growth rate throughout this projected duration; this upward trajectory is fundamentally supported by the escalating prevalence of long-term health conditions, greater spending on medical services, and supportive measures from governing bodies, while key developmental movements expected in the coming years encompass strategic alliances with AI entities, capitalizing on governmental assistance, integrating substantial data analytics into market evaluations, and forging partnerships across the industry landscape.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp

Which Drivers Are Supporting Growth Of The Hospital Acquired Infections Testing Kits Market?

Concerns regarding infections contracted within healthcare settings, referred to as hospital-acquired infections (HAIs) spanning both admitted and visiting patients, are escalating; these nosocomial ailments originate during stays at hospitals or clinics, and data from the Center for Disease Control and Prevention indicates that approximately 1.7 million individuals across the United States contract these infections while seeking treatment for unrelated conditions, tragically resulting in the deaths of over 98,000 patients, which represents roughly five percent of those affected, consequently fueling greater need for the market supplying testing kits designed to diagnose hospital-acquired infections.

What Are The Different Segment Classifications Within The Hospital Acquired Infections Testing Kits Market?

The hospital acquired infections testing kitsmarket covered in this report is segmented –

1) By Product: Consumables And Reagents, Instruments

2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others

3) By Pathogen Type: Viral, Bacterial, Fungal

4) By Application: Drug Resistance Testing, Disease Testing

Subsegments:

1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)

2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)

Which Trends Are Impacting The Hospital Acquired Infections Testing Kits Market?

Progress in diagnostic procedures utilized for identifying healthcare-associated infections, including flow cytometry, mass spectrometry, near-infrared spectroscopy, and various nucleic acid-based methods, is leading to increasingly precise information. Substantial improvements have been observed in mass spectrometers, devices capable of both precisely measuring predetermined substances and discerning previously unidentified chemical entities present in a specimen. A prime illustration is SCIEX’s X500 QTOF system, a device engineered to overcome contamination issues in a space-saving design while maintaining superior resolution and precision, thereby accelerating result delivery and enabling quicker, data-informed choices by the user.

Which Key Market Players Are Investing In Expansion And Innovation Of Hospital Acquired Infections Testing Kits Market?

Major companies operating in the hospital acquired infections testing kits market include Becton, Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, Hologic, Inc, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, Metall Zug (Belimed Group), Innovaccer, JD Health, CISCO Systems Inc, GE Healthcare, Honeywell Lifesciences, Zydus Cadila, ImmunoScience, CPC Diagnostics, Seegene, SD Biosensor, Vivacheck Lab, Fujirebio, Sysmex Corporation, Philip Healthcare, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, Bayer AG, Cantel Medical Corporation, Siemens Healthineers

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Which Geographies Are Emerging As Strong Markets For The Hospital Acquired Infections Testing Kits Industry?

North America was the largest region in the hospital-acquired infections testing kits market in 2024. Western Europe was the second largest region in the global hospital-acquired infections testing kits market share. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Hospital Acquired Infections Testing Kits Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2469&type=smp

Browse Through More Reports Similar to the Global Hospital Acquired Infections Testing Kits Market 2025, By The Business Research Company

Hospital Acquired Infection Control Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Healthcare Personal Protective Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-personal-protective-equipment-global-market-report

Hospital Supplies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-supplies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Hospital Acquired Infections Testing Kits Market Through 2034?

The market size for testing kits for hospital-acquired infections has seen considerable growth in recent times. Forecasts predict an increase from $4.54 billion in 2024 to $4.79 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.4%. The expansion in the past period is traced back to the rise in hospital-acquired infections (HAIs), an aging population, and an upswing in the number of surgeries.

In the ensuing years, the market for hospital-acquired infections testing kits is projected to witness robust expansion. It is set to escalate to $6.64 billion in 2029, advancing at a compound annual growth rate (CAGR) of 8.5%. This growth anticipated in the forecast span can be credited to factors like the upsurge in chronic diseases, escalating healthcare spending, and heightened government support propelling the growth. Notable trends for the projected period encompass collaboration with artificial intelligence firms, harnessing support from the government, integrating big data into market assessment, and forming partnerships with other market participants.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Hospital Acquired Infections Testing Kits Market?

There is a growing number of cases of infections contracted within hospital settings, referred to as hospital-acquired infections (HAIs), impacting both patients admitted to hospitals and those receiving outpatient services. These are illnesses that patients contract within medical facilities, such as hospitals and clinics. As an example, the Center for Disease Control and Prevention’s research discovered that about 1.7 million people in the USA contract hospital-acquired infections during their admission for other medical conditions, with roughly 5% (over 98,000 individuals) succumbing to these infections. As the rate of hospital-acquired infections escalates, so does the demand for testing kits in the hospital-acquired infections market.

Which Primary Segments of the Hospital Acquired Infections Testing Kits Market Are Driving Growth and Industry Transformations?

The hospital acquired infections testing kitsmarket covered in this report is segmented –

1) By Product: Consumables And Reagents, Instruments

2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others

3) By Pathogen Type: Viral, Bacterial, Fungal

4) By Application: Drug Resistance Testing, Disease Testing

Subsegments:

1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)

2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2469&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Hospital Acquired Infections Testing Kits Market?# Market?

North America was the largest region in the hospital-acquired infections testing kits market in 2024. Western Europe was the second largest region in the global hospital-acquired infections testing kits market share. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Most Significant Market Trends in the Hospital Acquired Infections Testing Kits Market?

Advancements in diagnostic tests used to diagnose Hospital Acquired Infections (HAIs), which include flow cytometry, mass spectrometry, near-infrared spectroscopy, and nucleic acid-based technologies, are delivering more precise data than ever before. Specifically, there have been notable improvements in mass spectrometers, which are used to quantify known substances and identify unknown ones within a sample. Highlighting this progress is the X500 QTOF by SCIEX, which efficiently addresses the issue of contamination with its compact design that still maintains high accuracy and resolution. This device hastens the results, enabling sped up data-dependent decision making.

View the full report here:

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

What Parameters Are Used to Define the Hospital Acquired Infections Testing Kits Market?

The hospital-acquired infection testing kits are tools used to check the infections people get while in a healthcare facility. Hospital-acquired infections testing kits are used to check the infections associated with pathogens such as vancomycin-resistant enterococci (VRE), methicillin-resistant staphylococcus aureus (MRSA), multi-resistant gram-negative bacilli, norovirus, and Clostridium difficile.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2469

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Forecast for the Hospital Acquired Infections Testing Kits Market from 2024 to 2025?#_x000D_

In recent years, the market size for testing kits for hospital acquired infections has seen robust growth. Projected growth from $4.54 billion in 2024 to $4.83 billion in 2025 is expected, with a compound annual growth rate (CAGR) of 6.4%. This upsurge during the historical period can be linked to an increase in hospital-acquired infections (HAIs), an escalating aging populace, and a rise in the number of surgical procedures._x000D_

_x000D_

#What Is the Projected Market Size of the Hospital Acquired Infections Testing Kits Market?#_x000D_

The market for testing kits for hospital acquired infections is predicted to witness robust expansion in the coming years, reaching a valuation of $6.78 billion in 2029, with a compound annual growth rate (CAGR) of 8.8%. Various factors such as the surge in chronic illness, increase in healthcare spending, and enhanced government backing can contribute to the growth in the forecast period. Looking ahead, the market will likely see trends like partnerships with artificial intelligence firms, getting support from the government, integrating big data in their market research and collaborations with other market participants._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp_x000D_

_x000D_

#Who are the Major Competitors in the Hospital Acquired Infections Testing Kits Market Outlook?#_x000D_

Major companies operating in the hospital acquired infections testing kits market include Becton, Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, Hologic, Inc, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, Metall Zug (Belimed Group), Innovaccer, JD Health, CISCO Systems Inc, GE Healthcare, Honeywell Lifesciences, Zydus Cadila, ImmunoScience, CPC Diagnostics, Seegene, SD Biosensor, Vivacheck Lab, Fujirebio, Sysmex Corporation, Philip Healthcare, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, Bayer AG, Cantel Medical Corporation, Siemens Healthineers_x000D_

_x000D_

#What Is Fueling Growth in the Hospital Acquired Infections Testing Kits Market?#_x000D_

The prevalence of hospital-acquired infections (HAIs), which impact both hospitalized and non-hospitalized patients, is escalating. These infections, also referred to as nosocomial infections, are contracted in healthcare facilities like hospitals and clinics. To illustrate, data from the Center for Disease Control and Prevention indicates that roughly 1.7 million people in the USA contract these infections while hospitalized for unrelated health matters. Furthermore, approximately 5% of these patients, amounting to over 98,000 individuals, tragically lose their lives due to these infections. This escalating occurrence of hospital-acquired infections triggers a growing demand for testing kits in the hospital-acquired infections market._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=2469&type=smp_x000D_

_x000D_

#Which Hospital Acquired Infections Testing Kits Market Segments Are Growing the Fastest?#_x000D_

The hospital acquired infections testing kits market covered in this report is segmented –_x000D_

_x000D_

1) By Product: Consumables And Reagents, Instruments_x000D_

2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others_x000D_

3) By Pathogen Type: Viral, Bacterial, Fungal_x000D_

4) By Application: Drug Resistance Testing, Disease Testing_x000D_

_x000D_

Subsegments:_x000D_

1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)_x000D_

2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)_x000D_

_x000D_

#Which Industry Trends Are Shaping the Future of the Hospital Acquired Infections Testing Kits Market?#_x000D_

Advancements in diagnostic tests used for decoding HAIs such as flow cytometry, mass spectrometry, near-infrared spectroscopy, and nucleic acid-based technologies, are offering enhanced precision in the data they produce. There’s a notable progression in mass spectrometers, instruments that evaluate known substances and pinpoint unfamiliar compounds in a specimen. For example, the X500 QTOF from SCIEX is designed to address contamination issues in a compact form that doesn’t sacrifice resolution or accuracy. It delivers results faster, enabling the user to make evidence-based decisions more promptly._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report_x000D_

_x000D_

#Which Countries Are Leading the Hospital Acquired Infections Testing Kits Market?#_x000D_

North America was the largest region in the hospital-acquired infections testing kits market in 2024. Western Europe was the second largest region in the global hospital-acquired infections testing kits market share. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2469_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the hospital acquired infections testing kits market, and how is it changing globally?_x000D_

2. Who are the major companies in the hospital acquired infections testing kits market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the hospital acquired infections testing kits market right now?_x000D_

4. Which products or customer segments are growing the most in the hospital acquired infections testing kits market?_x000D_

5. What factors are helping or slowing down the growth of the hospital acquired infections testing kits market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 2071930708_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model